The receptor for advanced glycation end-products (RAGE) is involved in the pathogenesis of AD, and that sustained Aβ interaction with RAGE at the blood–brain barrier, or in neuronal or microglial cells, is an important element of amyloid plaque formation and chronic neural dysfunction [37]. The gene discussed is AGER; the disease is amyloidosis.